<DOC>
	<DOC>NCT00230971</DOC>
	<brief_summary>This is a study of the safety and efficacy of tigecycline to ceftriaxone sodium plus metronidazole in hospitalized subjects with cIAI. Subjects will be followed for efficacy through the test-of-cure assessment. Safety evaluations will occur through the treatment and post-treatment periods and continue through resolution or stability of the adverse event(s).</brief_summary>
	<brief_title>Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Appendicitis</mesh_term>
	<mesh_term>Abscess</mesh_term>
	<mesh_term>Peritonitis</mesh_term>
	<mesh_term>Diverticulitis</mesh_term>
	<mesh_term>Cholecystitis</mesh_term>
	<mesh_term>Acalculous Cholecystitis</mesh_term>
	<mesh_term>Intraabdominal Infections</mesh_term>
	<mesh_term>Abdominal Abscess</mesh_term>
	<mesh_term>Ceftriaxone</mesh_term>
	<mesh_term>Tigecycline</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>Clinical diagnosis of complicated intraabdominal infection that requires surgery within 24 hours. Fever plus other symptoms such as nausea, vomiting, abdominal pain. Cancer Medicines that suppress the immune system Dialysis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Intra-Abdominal Infections</keyword>
	<keyword>Abscess</keyword>
</DOC>